GL1X · GenesisL1 explorer

MolNFT v1 · #154460 · protein

Crystal structure of human KLK4 and SPINK2 derived KLK4 inhibitor complex

6KBR · Kallikrein-4: “Crystal structure of human KLK4 and SPINK2 derived KLK4 inhibitor complex”. X-ray diffraction, 2 pockets (best druggability 0.41). MolNFT v1 #154460 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6KBR
Type
protein
Length
278 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kallikrein-4; K41043
EC
3.4.21.-
UniProt
Q9Y5K2
Pockets
2 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKallikrein-4 (EC 3.4.21.-)protein22310% helix, 37% strandQ9Y5K2
CK41043protein5525% helix, 20% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11280.410.7520empty
21220.410.7621empty

Interfaces

1 interface between chains.

  • A–C · 885 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide (disulfide).

Compared structures

  • 6KBR · Crystal structure of Human KLK4 and SPINK2 derived KLK4 inhibitor complex · the same entry in another collection · chain C against C, TM-score 1.00
  • Q9Y5K2 · AlphaFold monomer V2.0 prediction for kallikrein-4 (Q9Y5K2) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.